Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Sarepta Therapeutics - 27 Year Stock Price History | SRPT

Historical daily share price chart and data for Sarepta Therapeutics since 1997 adjusted for splits and dividends. The latest closing stock price for Sarepta Therapeutics as of April 25, 2024 is 127.39.
  • The all-time high Sarepta Therapeutics stock closing price was 178.74 on December 22, 2020.
  • The Sarepta Therapeutics 52-week high stock price is 159.89, which is 25.5% above the current share price.
  • The Sarepta Therapeutics 52-week low stock price is 55.25, which is 56.6% below the current share price.
  • The average Sarepta Therapeutics stock price for the last 52 weeks is 114.41.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Sarepta Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 122.5601 96.2100 141.5300 93.7000 127.3900 32.11%
2023 116.7710 124.8400 157.1900 67.3100 96.4300 -25.58%
2022 91.8743 90.4200 132.1300 62.6900 129.5800 43.90%
2021 82.5635 165.2900 168.9500 65.9700 90.0500 -47.18%
2020 137.8229 129.0900 178.7400 82.3800 170.4900 32.12%
2019 117.1305 107.5000 156.9100 72.8100 129.0400 18.24%
2018 105.9535 58.2500 161.5100 54.0200 109.1300 96.14%
2017 39.1454 27.9200 56.7500 27.6700 55.6400 102.84%
2016 26.6381 38.0700 62.3500 10.7400 27.4300 -28.90%
2015 25.1902 14.9400 41.7900 11.6100 38.5800 166.62%
2014 24.1064 20.5800 38.9100 12.6000 14.4700 -28.96%
2013 33.2875 26.2400 53.8100 12.8900 20.3700 -21.05%
2012 11.8641 4.4400 44.9300 3.4600 25.8000 477.18%
2011 8.6942 13.0200 15.4800 3.2400 4.4700 -64.86%
2010 10.0156 9.4800 13.0800 6.9000 12.7200 45.21%
2009 8.0035 4.0800 14.8200 3.3006 8.7600 121.88%
2008 7.1255 8.5200 11.2800 2.8800 3.9480 -53.33%
2007 16.1696 18.5400 19.2000 7.8600 8.4600 -55.66%
2006 28.7698 20.3400 51.9000 15.4800 19.0800 -7.83%
2005 15.9895 13.5000 24.8405 12.0000 20.7000 46.81%
2004 16.0193 24.4800 28.5000 9.5400 14.1000 -42.26%
2003 29.1107 29.2200 42.3000 12.2400 24.4200 -18.60%
2002 37.5316 66.2400 77.8200 16.1940 30.0000 -54.21%
2001 44.1418 25.8780 67.1400 18.0000 65.5200 129.89%
2000 61.9330 34.5000 157.1400 24.3780 28.5000 -12.65%
1999 23.7957 24.3780 43.5000 15.3780 32.6280 35.95%
1998 32.6481 40.8780 45.9360 16.5000 24.0000 -41.82%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $11.667B $1.243B
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-based therapeutics targeting rare and infectious diseases. It concentrates on the development of exon-skipping drug candidates targeting Duchenne muscular dystrophy (DMD), a rare genetic disorder affecting children. The company received accelerated approval for Exondys 51, Amondys 45 (casimersen) and Vyondys 53 (golodirsen). Exondys 51 is Sarepta's first PMO-based technology to be granted accelerated approval by the FDA. The company is conducting a confirmatory study on the clinical benefits of these drugs for gaining continued approval. The rest of its exon-skipping DMD pipeline includes a PPMO-based, exon 51 skipping candidate, SRP-5051. Sarepta is also developing gene therapies for treating DMD, Limb-girdle muscular dystrophy and central nervous system disorders including Mucopolysaccharidosis type IIIA and Pompe Disease.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $146.436B 14.64
Vertex Pharmaceuticals (VRTX) United States $103.580B 29.82
Regeneron Pharmaceuticals (REGN) United States $99.504B 24.12
Bristol Myers Squibb (BMY) United States $99.027B 6.51
CSL (CSLLY) Australia $87.082B 0.00
GSK (GSK) United Kingdom $84.680B 10.61
Gilead Sciences (GILD) United States $83.520B 9.98
Moderna (MRNA) United States $41.676B 0.00
Biogen (BIIB) United States $29.361B 13.47
Argenex SE (ARGX) Netherlands $22.287B 0.00
BioNTech SE (BNTX) Germany $20.941B 21.38
Illumina (ILMN) United States $19.568B 141.23
Genmab (GMAB) Denmark $18.825B 24.13
Alnylam Pharmaceuticals (ALNY) United States $18.111B 0.00
BioMarin Pharmaceutical (BMRN) United States $17.213B 67.56
BeiGene (BGNE) Cayman Islands $13.784B 0.00
Incyte (INCY) United States $11.617B 19.31
Exact Sciences (EXAS) United States $11.480B 0.00
Bio-Techne Corp (TECH) United States $9.985B 37.15
QIAGEN (QGEN) Netherlands $9.475B 19.61
Repligen (RGEN) United States $9.373B 97.03
Roivant Sciences (ROIV) United Kingdom $8.784B 0.00
Ascendis Pharma (ASND) Denmark $8.337B 0.00
Legend Biotech (LEGN) United States $8.217B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 23.78
Viking Therapeutics (VKTX) United States $7.172B 0.00
Intra-Cellular Therapies (ITCI) United States $7.079B 0.00
Exelixis (EXEL) United States $6.990B 37.05
Cytokinetics (CYTK) United States $6.988B 0.00
Vaxcyte (PCVX) United States $6.558B 0.00
Apellis Pharmaceuticals (APLS) United States $6.021B 0.00
Blueprint Medicines (BPMC) United States $5.646B 0.00
Halozyme Therapeutics (HALO) United States $4.970B 15.34
CRISPR Therapeutics AG (CRSP) Switzerland $4.724B 0.00
Krystal Biotech (KRYS) United States $4.535B 0.00
Zealand Pharma (ZLDPF) Denmark $4.494B 0.00
Nuvalent (NUVL) United States $4.305B 0.00
Immunovant (IMVT) United States $4.184B 0.00
Alkermes (ALKS) Ireland $4.170B 22.01
Insmed (INSM) United States $3.834B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.644B 0.00
Biohaven (BHVN) United States $3.417B 0.00
Axsome Therapeutics (AXSM) United States $3.372B 0.00
Fortrea Holdings (FTRE) United States $3.329B 0.00
Iovance Biotherapeutics (IOVA) United States $3.271B 0.00
ImmunityBio (IBRX) United States $3.263B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.208B 0.00
SpringWorks Therapeutics (SWTX) United States $3.201B 0.00
Amicus Therapeutics (FOLD) United States $3.113B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.980B 0.00
IDEAYA Biosciences (IDYA) United States $2.979B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.913B 0.00
Arcellx (ACLX) United States $2.815B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.734B 0.00
Apogee Therapeutics (APGE) United States $2.720B 0.00
MorphoSys AG (MOR) Germany $2.719B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.711B 0.00
Certara (CERT) United States $2.635B 56.72
Janux Therapeutics (JANX) United States $2.491B 0.00
Merus (MRUS) Netherlands $2.463B 0.00
CG Oncology (CGON) United States $2.402B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.388B 0.00
Vericel (VCEL) United States $2.231B 0.00
Arvinas (ARVN) United States $2.223B 0.00
Denali Therapeutics (DNLI) United States $2.218B 0.00
Guardant Health (GH) United States $2.203B 0.00
Vera Therapeutics (VERA) United States $2.175B 0.00
Kymera Therapeutics (KYMR) United States $2.152B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.139B 0.00
Celldex Therapeutics (CLDX) United States $2.069B 0.00
Intellia Therapeutics (NTLA) United States $2.042B 0.00
Keros Therapeutics (KROS) United States $2.028B 0.00
Avidity Biosciences (RNA) United States $2.000B 0.00
Geron (GERN) United States $1.958B 0.00
Galapagos (GLPG) Belgium $1.896B 0.00
Sana Biotechnology (SANA) United States $1.891B 0.00
Beam Therapeutics (BEAM) United States $1.872B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.821B 0.00
NeoGenomics (NEO) United States $1.791B 0.00
Twist Bioscience (TWST) United States $1.778B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.766B 0.00
Structure Therapeutics (GPCR) United States $1.698B 0.00
Myriad Genetics (MYGN) United States $1.686B 0.00
Bavarian Nordic (BVNRY) Denmark $1.675B 5.50
Harmony Biosciences Holdings (HRMY) United States $1.660B 13.79
Inhibrx (INBX) United States $1.629B 0.00
Zai Lab (ZLAB) China $1.554B 0.00
Neumora Therapeutics (NMRA) United States $1.524B 0.00
Edgewise Therapeutics (EWTX) United States $1.500B 0.00
Protagonist Therapeutics (PTGX) United States $1.498B 0.00
Dynavax Technologies (DVAX) United States $1.494B 0.00
ADMA Biologics Inc (ADMA) United States $1.474B 0.00
Kura Oncology (KURA) United States $1.428B 0.00
Arcus Biosciences (RCUS) United States $1.403B 0.00
Akero Therapeutics (AKRO) United States $1.401B 0.00
Morphic Holding (MORF) United States $1.386B 0.00
ANI Pharmaceuticals (ANIP) United States $1.379B 16.95
Gyre Therapeutics (GYRE) United States $1.371B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.327B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.261B 0.00
Ligand Pharmaceuticals (LGND) United States $1.257B 15.57
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.232B 0.00
Spyre Therapeutics (SYRE) United States $1.193B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.181B 0.00
AbCellera Biologics (ABCL) Canada $1.142B 0.00
MannKind (MNKD) United States $1.134B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.132B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.121B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.120B 0.00
Prothena (PRTA) Ireland $1.104B 0.00
Scholar Rock Holding (SRRK) United States $1.097B 0.00
Belite Bio (BLTE) United States $1.086B 0.00
Vir Biotechnology (VIR) United States $1.081B 0.00
Abivax SA (ABVX) France $1.000B 0.00
Liquidia Technologies (LQDA) United States $0.954B 0.00
MiMedx (MDXG) United States $0.949B 214.33
Immatics (IMTX) Germany $0.859B 0.00
Immunome (IMNM) United States $0.852B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.847B 0.00
Tyra Biosciences (TYRA) United States $0.840B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.835B 0.00
Tango Therapeutics (TNGX) United States $0.828B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.821B 0.00
Viridian Therapeutics (VRDN) United States $0.818B 0.00
89BIO (ETNB) United States $0.817B 0.00
Cullinan Therapeutics (CGEM) United States $0.814B 0.00
ALX Oncology Holdings (ALXO) United States $0.811B 0.00
REGENXBIO (RGNX) United States $0.787B 0.00
Kyverna Therapeutics (KYTX) United States $0.764B 0.00
PureTech Health (PRTC) United States $0.742B 0.00
Cytek Biosciences (CTKB) United States $0.740B 0.00
CARGO Therapeutics (CRGX) United States $0.738B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.726B 0.00
Pliant Therapeutics (PLRX) United States $0.718B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.711B 0.00
Mesoblast (MESO) Australia $0.710B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.681B 0.00
Praxis Precision Medicines (PRAX) United States $0.677B 0.00
Nurix Therapeutics (NRIX) United States $0.676B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.669B 0.00
Pharming Group (PHAR) Netherlands $0.660B 0.00
Disc Medicine (IRON) United States $0.659B 0.00
EnGene Holdings (ENGN) United States $0.643B 0.00
Dianthus Therapeutics (DNTH) United States $0.626B 0.00
HilleVax (HLVX) United States $0.625B 0.00
Cogent Biosciences (COGT) United States $0.625B 0.00
Pharming Group (PHGUF) Netherlands $0.620B 0.00
WAVE Life Sciences (WVE) Singapore $0.613B 0.00
Stoke Therapeutics (STOK) United States $0.608B 0.00
Cabaletta Bio (CABA) United States $0.607B 0.00
Zymeworks (ZYME) United States $0.603B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.594B 0.00
Aerovate Therapeutics (AVTE) United States $0.591B 0.00
Novavax (NVAX) United States $0.581B 0.00
Nuvation Bio (NUVB) United States $0.580B 0.00
GH Research (GHRS) Ireland $0.576B 0.00
Olema Pharmaceuticals (OLMA) United States $0.568B 0.00
Prime Medicine (PRME) United States $0.564B 0.00
Mineralys Therapeutics (MLYS) United States $0.564B 0.00
CureVac (CVAC) Germany $0.562B 0.00
Northwest Biotherapeutics (NWBO) United States $0.554B 0.00
Castle Biosciences (CSTL) United States $0.545B 0.00
Oric Pharmaceuticals (ORIC) United States $0.544B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.534B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Allogene Therapeutics (ALLO) United States $0.519B 0.00
Celcuity (CELC) United States $0.516B 0.00
AnaptysBio (ANAB) United States $0.516B 0.00
ArriVent BioPharma (AVBP) United States $0.512B 0.00
Absci (ABSI) United States $0.512B 0.00
Alector (ALEC) United States $0.503B 0.00
Adlai Nortye (ANL) Cayman Islands $0.500B 0.00
Astria Therapeutics (ATXS) United States $0.494B 0.00
Arbutus Biopharma (ABUS) United States $0.494B 0.00
Applied Therapeutics (APLT) United States $0.492B 0.00
Fate Therapeutics (FATE) United States $0.489B 0.00
Oculis Holding AG (OCS) Switzerland $0.485B 0.00
Shattuck Labs (STTK) United States $0.471B 0.00
IGM Biosciences (IGMS) United States $0.468B 0.00
Third Harmonic Bio (THRD) United States $0.462B 0.00
Humacyte (HUMA) United States $0.455B 0.00
Fulcrum Therapeutics (FULC) United States $0.452B 0.00
ACELYRIN, INC (SLRN) United States $0.452B 0.00
C4 Therapeutics (CCCC) United States $0.444B 0.00
Editas Medicine (EDIT) United States $0.440B 0.00
Avid Bioservices (CDMO) United States $0.432B 0.00
Entrada Therapeutics (TRDA) United States $0.418B 0.00
Travere Therapeutics (TVTX) United States $0.415B 0.00
Voyager Therapeutics (VYGR) United States $0.411B 2.45
Annexon (ANNX) United States $0.401B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.396B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.394B 0.00
MaxCyte (MXCT) United States $0.390B 0.00
Replimune (REPL) United States $0.389B 0.00
Neurogene (NGNE) United States $0.389B 0.00
Biomea Fusion (BMEA) United States $0.387B 0.00
Anika Therapeutics (ANIK) United States $0.385B 0.00
PepGen (PEPG) United States $0.383B 0.00
Alto Neuroscience (ANRO) United States $0.382B 0.00
ITeos Therapeutics (ITOS) United States $0.379B 0.00
Adaptive Biotechnologies (ADPT) United States $0.377B 0.00
FibroBiologics (FBLG) United States $0.376B 0.00
Revance Therapeutics (RVNC) United States $0.372B 0.00
Amarin (AMRN) Ireland $0.361B 0.00
Nkarta (NKTX) United States $0.354B 0.00
Precigen (PGEN) United States $0.353B 0.00
TScan Therapeutics (TCRX) United States $0.353B 0.00
Aura Biosciences (AURA) United States $0.351B 0.00
Rani Therapeutics Holdings (RANI) United States $0.351B 0.00
Mersana Therapeutics (MRSN) United States $0.349B 0.00
Caribou Biosciences (CRBU) United States $0.348B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.347B 0.00
Tenaya Therapeutics (TNYA) United States $0.344B 0.00
Urogen Pharma (URGN) United States $0.333B 0.00
Jasper Therapeutics (JSPR) United States $0.332B 0.00
Solid Biosciences (SLDB) United States $0.332B 0.00
MeiraGTx Holdings (MGTX) United States $0.312B 0.00
Atea Pharmaceuticals (AVIR) United States $0.311B 0.00
Terns Pharmaceuticals (TERN) United States $0.307B 0.00
Ocugen (OCGN) United States $0.304B 0.00
Nautilus Biotechnology (NAUT) United States $0.300B 0.00
Ventyx Biosciences (VTYX) United States $0.299B 0.00
XOMA (XOMA) United States $0.298B 0.00
Kamada (KMDA) Israel $0.298B 22.52
CorMedix Inc (CRMD) United States $0.292B 0.00
Contineum Therapeutics (CTNM) United States $0.291B 0.00
Erasca (ERAS) United States $0.285B 0.00
Renovaro (RENB) United States $0.283B 0.00
Anavex Life Sciences (AVXL) United States $0.280B 0.00
Werewolf Therapeutics (HOWL) United States $0.277B 0.00
Rapt Therapeutics (RAPT) United States $0.275B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.274B 0.00
Inozyme Pharma (INZY) United States $0.272B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.262B 91.20
Oxford BioMedica (OXBDF) United Kingdom $0.262B 0.00
ChromaDex (CDXC) United States $0.256B 0.00
Invivyd (IVVD) United States $0.254B 0.00
XBiotech (XBIT) United States $0.246B 0.00
Inovio Pharmaceuticals (INO) United States $0.237B 0.00
Verastem (VSTM) United States $0.236B 0.00
AC Immune (ACIU) Switzerland $0.234B 0.00
Puma Biotechnology (PBYI) United States $0.233B 10.50
Coherus BioSciences (CHRS) United States $0.229B 0.00
Prima BioMed (IMMP) Australia $0.228B 0.00
23andMe Holding (ME) United States $0.226B 0.00
Ovid Therapeutics (OVID) United States $0.223B 0.00
2seventy Bio (TSVT) United States $0.219B 0.00
UniQure (QURE) Netherlands $0.218B 0.00
Sutro Biopharma (STRO) United States $0.217B 0.00
X4 Pharmaceuticals (XFOR) United States $0.217B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
Adverum Biotechnologies (ADVM) United States $0.211B 0.00
G1 Therapeutics (GTHX) United States $0.208B 0.00
Design Therapeutics (DSGN) United States $0.206B 0.00
Compass Therapeutics (CMPX) United States $0.204B 0.00
Opthea (OPT) Australia $0.200B 0.00
Poseida Therapeutics (PSTX) United States $0.200B 0.00
Innate Pharma S.A (IPHA) France $0.199B 0.00
Codexis (CDXS) United States $0.197B 0.00
INmune Bio (INMB) United States $0.193B 0.00
Lifecore Biomedical (LFCR) United States $0.192B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.191B 0.00
Alimera Sciences (ALIM) United States $0.190B 0.00
Elevation Oncology (ELEV) United States $0.189B 0.00
Akoya Biosciences (AKYA) United States $0.188B 0.00
Cardiff Oncology (CRDF) United States $0.187B 0.00
Trevi Therapeutics (TRVI) United States $0.183B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.179B 0.00
Candel Therapeutics (CADL) United States $0.178B 0.00
Kodiak Sciences (KOD) United States $0.178B 0.00
GENFIT S.A (GNFT) France $0.174B 0.00
Inventiva S.A (IVA) France $0.170B 0.00
Adocia (ADOCY) France $0.169B 0.00
Compugen (CGEN) Israel $0.165B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.164B 0.00
Greenwich LifeSciences (GLSI) United States $0.163B 0.00
ScPharmaceuticals (SCPH) United States $0.162B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.160B 0.00
Gossamer Bio (GOSS) United States $0.160B 0.00
Skye Bioscience (SKYE) United States $0.159B 0.00
Agenus (AGEN) United States $0.155B 0.00
Adicet Bio (ACET) United States $0.154B 0.00
BioStem Technologies (BSEM) $0.152B 0.00
CervoMed (CRVO) United States $0.152B 0.00
I-Mab (IMAB) China $0.146B 0.00
Zura Bio (ZURA) United States $0.143B 0.00
Scilex Holding (SCLX) United States $0.141B 0.00
Molecular Partners AG (MOLN) Switzerland $0.141B 0.00
Annovis Bio (ANVS) United States $0.140B 0.00
Cellectis S.A (CLLS) France $0.139B 0.00
Syros Pharmaceuticals (SYRS) United States $0.136B 0.00
DBV Technologies S.A (DBVT) France $0.133B 0.00
Sagimet Biosciences (SGMT) United States $0.133B 0.00
Omega Therapeutics (OMGA) United States $0.129B 0.00
VistaGen Therapeutics (VTGN) United States $0.128B 0.00
Coya Therapeutics (COYA) United States $0.123B 0.00
Repare Therapeutics (RPTX) Canada $0.122B 0.00
Adagene (ADAG) China $0.121B 0.00
Nuvectis Pharma (NVCT) United States $0.119B 0.00
PDS Biotechnology (PDSB) United States $0.119B 0.00
Vor Biopharma (VOR) $0.119B 0.00
Rezolute (RZLT) United States $0.116B 0.00
Seer (SEER) United States $0.115B 0.00
Emergent Biosolutions (EBS) United States $0.114B 0.00
BioAtla (BCAB) United States $0.113B 0.00
Cartesian Therapeutics (RNAC) United States $0.112B 0.00
Immunic (IMUX) United States $0.112B 0.00
CytomX Therapeutics (CTMX) United States $0.110B 0.00
Seres Therapeutics (MCRB) United States $0.110B 0.00
TELA Bio (TELA) United States $0.110B 0.00
ATyr Pharma (LIFE) United States $0.109B 0.00
Oncobiologics (OTLK) United States $0.107B 0.00
BioHarvest Sciences (CNVCF) Canada $0.105B 0.00
Vigil Neuroscience (VIGL) United States $0.104B 0.00
Sangamo Therapeutics (SGMO) United States $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Bluebird Bio (BLUE) United States $0.101B 0.00
BioXcel Therapeutics (BTAI) United States $0.100B 0.00
Clearside Biomedical (CLSD) United States $0.100B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.098B 0.00
IO Biotech (IOBT) Denmark $0.096B 0.00
Elicio Therapeutics (ELTX) United States $0.095B 0.00
BeyondSpring (BYSI) United States $0.095B 0.00
DiaMedica Therapeutics (DMAC) United States $0.093B 0.00
Genelux (GNLX) United States $0.093B 0.00
Allakos (ALLK) United States $0.090B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.088B 0.00
Curis (CRIS) United States $0.087B 0.00
Abeona Therapeutics (ABEO) United States $0.087B 0.00
Galena Biopharma (SLS) United States $0.087B 0.00
Q32 Bio (QTTB) United States $0.087B 0.00
Atara Biotherapeutics (ATRA) United States $0.085B 0.00
Leap Therapeutics (LPTX) United States $0.084B 0.00
HOOKIPA Pharma (HOOK) United States $0.084B 0.00
Aileron Therapeutics (ALRN) United States $0.084B 0.00
Eton Pharmaceuticals (ETON) United States $0.082B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.081B 0.00
InflaRx (IFRX) Germany $0.080B 0.00
Oncolytics Biotech (ONCY) Canada $0.080B 0.00
Gritstone Bio (GRTS) United States $0.080B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.080B 0.00
Cognition Therapeutics (CGTX) United States $0.078B 0.00
Athira Pharma (ATHA) United States $0.077B 0.00
VTv Therapeutics (VTVT) United States $0.077B 0.00
Spero Therapeutics (SPRO) United States $0.077B 2.84
Passage Bio (PASG) United States $0.076B 0.00
Connect Biopharma Holdings (CNTB) United States $0.075B 0.00
YS Biopharma (YS) China $0.075B 0.00
Affimed (AFMD) Germany $0.074B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.074B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.072B 0.00
AN2 Therapeutics (ANTX) United States $0.071B 0.00
Turnstone Biologics (TSBX) United States $0.071B 0.00
Elutia (ELUT) United States $0.070B 0.00
Alpha Teknova (TKNO) United States $0.070B 0.00
Instil Bio (TIL) United States $0.070B 0.00
Landos Biopharma (LABP) United States $0.069B 0.00
Cue Biopharma (CUE) United States $0.069B 0.00
Precision BioSciences (DTIL) United States $0.068B 0.00
MediciNova (MNOV) United States $0.066B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.066B 0.00
Celularity (CELU) United States $0.066B 0.00
Equillium (EQ) United States $0.063B 0.00
Aligos Therapeutics (ALGS) United States $0.063B 0.00
Ikena Oncology (IKNA) United States $0.062B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.062B 0.00
Rallybio (RLYB) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
CalciMedica (CALC) United States $0.059B 0.00
Kezar Life Sciences (KZR) United States $0.058B 0.00
LENZ Therapeutics (LENZ) United States $0.058B 0.00
Lantern Pharma (LTRN) United States $0.058B 0.00
Kronos Bio (KRON) United States $0.058B 0.00
HCW Biologics (HCWB) United States $0.057B 0.00
Immix Biopharma (IMMX) United States $0.056B 0.00
Cidara Therapeutics (CDTX) United States $0.056B 0.00
Intensity Therapeutics (INTS) United States $0.055B 0.00
Enzo Biochem (ENZ) United States $0.054B 0.00
AVROBIO (AVRO) United States $0.053B 0.00
ARCA Biopharma (ABIO) United States $0.053B 0.00
Checkpoint Therapeutics (CKPT) United States $0.051B 0.00
Ocean Biomedical (OCEA) United States $0.049B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.049B 0.00
Genenta Science S.p.A (GNTA) Italy $0.046B 0.00
Beyond Air (XAIR) United States $0.046B 0.00
Quince Therapeutics (QNCX) United States $0.046B 0.00
Bolt Biotherapeutics (BOLT) United States $0.046B 0.00
Immuneering (IMRX) United States $0.044B 0.00
Prenetics Global (PRE) Cayman Islands $0.044B 0.00
Aadi Bioscience (AADI) United States $0.044B 0.00
Dyadic (DYAI) United States $0.043B 0.00
Clene (CLNN) United States $0.043B 0.00
Bionano Genomics (BNGO) United States $0.042B 0.00
Apollomics (APLM) United States $0.041B 0.00
Estrella Immunopharma (ESLA) United States $0.041B 0.00
OKYO Pharma (OKYO) $0.041B 0.00
SAB Biotherapeutics (SABS) United States $0.041B 0.00
NextCure (NXTC) United States $0.040B 0.00
NKGen Biotech (NKGN) United States $0.039B 0.00
Carmell (CTCX) United States $0.039B 0.00
Ocuphire Pharma (OCUP) United States $0.038B 0.00
Cyclo Therapeutics (CYTH) United States $0.037B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.037B 0.00
Promis Neurosciences (PMN) Canada $0.037B 0.00
Cara Therapeutics (CARA) United States $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
BRIACELL THERAP (BCTX) Canada $0.035B 0.00
Fortress Biotech (FBIO) United States $0.034B 0.00
IN8bio (INAB) United States $0.034B 0.00
Theratechnologies (THTX) Canada $0.033B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.032B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
Femasys (FEMY) United States $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Lexaria Bioscience (LEXX) Canada $0.028B 0.00
BioAffinity Technologies (BIAF) United States $0.028B 0.00
Aprea Therapeutics (APRE) United States $0.028B 0.00
Eyenovia (EYEN) United States $0.028B 0.00
Evogene (EVGN) Israel $0.028B 0.00
Pluri (PLUR) Israel $0.026B 0.00
Forte Biosciences (FBRX) United States $0.026B 0.00
Sensei Biotherapeutics (SNSE) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Semper Paratus Acquisition (TVGN) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Lumos Pharma (LUMO) United States $0.023B 0.00
Biora Therapeutics (BIOR) United States $0.022B 0.00
Synlogic (SYBX) United States $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.022B 0.00
RenovoRx (RNXT) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.018B 0.00
Galecto (GLTO) Denmark $0.018B 0.00
KALA BIO (KALA) United States $0.018B 0.00
Benitec Biopharma (BNTC) United States $0.017B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
Vaxxinity (VAXX) United States $0.017B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.017B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
ABVC BioPharma (ABVC) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.015B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Purple Biotech (PPBT) Israel $0.013B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Senti Biosciences (SNTI) United States $0.013B 0.00
Imunon (IMNN) United States $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Galera Therapeutics (GRTX) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
Telesis Bio (TBIO) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.009B 0.00
Eterna Therapeutics (ERNA) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Virios Therapeutics (VIRI) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.008B 0.00
TFF Pharmaceuticals (TFFP) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Chemomab Therapeutics (CMMB) Israel $0.007B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Kineta (KA) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Kintara Therapeutics (KTRA) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.005B 0.00
NexImmune (NEXI) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.31
Tharimmune (THAR) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Longeveron (LGVN) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Seelos Therapeutics (SEEL) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Biophytis SA (BPTS) France $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.000B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00